These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 23225133)

  • 1. Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.
    Maisch B; Pankuweit S
    Heart Fail Rev; 2013 Nov; 18(6):761-95. PubMed ID: 23225133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.
    Maisch B; Pankuweit S
    Herz; 2012 Sep; 37(6):644-56. PubMed ID: 22996288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment options in myocarditis and inflammatory cardiomyopathy : Focus on i. v. immunoglobulins.
    Maisch B; Alter P
    Herz; 2018 Aug; 43(5):423-430. PubMed ID: 29947834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options.
    Maisch B
    Front Cardiovasc Med; 2019; 6():48. PubMed ID: 31032264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins.
    Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S
    Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress.
    Kishimoto C; Shioji K; Kinoshita M; Iwase T; Tamaki S; Fujii M; Murashige A; Maruhashi H; Takeda S; Nonogi H; Hashimoto T
    Int J Cardiol; 2003 Oct; 91(2-3):173-8. PubMed ID: 14559127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilated cardiomyopathy update: infectious-immune theory revisited.
    Kawai C; Matsumori A
    Heart Fail Rev; 2013 Nov; 18(6):703-14. PubMed ID: 23892949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory dilated cardiomyopathy : Etiology and clinical management.
    Maisch B; Pankuweit S
    Herz; 2020 May; 45(3):221-229. PubMed ID: 32123933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute viral myocarditis: current concepts in diagnosis and treatment.
    Shauer A; Gotsman I; Keren A; Zwas DR; Hellman Y; Durst R; Admon D
    Isr Med Assoc J; 2013 Mar; 15(3):180-5. PubMed ID: 23662385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
    Castellano G; Affuso F; Di Conza P; Fazio S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
    Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ Update 2001. Myocarditis--cardiomyopathy].
    Strauer BE; Kandolf R; Mall G; Maisch B; Mertens T; Figulla HR; Schwartzkopff B; Brehm M; Schultheiss HP
    Med Klin (Munich); 2001 Oct; 96(10):608-25. PubMed ID: 11715333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy].
    Noutsias M; Pauschinger M; Kühl U; Schultheiss HP
    MMW Fortschr Med; 2002 Apr; 144(14):36-40. PubMed ID: 12014275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.
    Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S
    Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppressive therapy of myocarditis?].
    Schultheiss HP; Kühl U; Janda I; Schanwell M; Strauer BE
    Herz; 1992 Apr; 17(2):112-21. PubMed ID: 1577363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis and treatment of cardiomyopathy and myocarditis.
    O'Connell JB; Costanzo-Nordin MR; Engelmeier RS; Wallis DE; Robinson JA; Scanlon PJ
    Heart Vessels Suppl; 1985; 1():175-9. PubMed ID: 3843581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocarditis in childhood: results of a decade's research].
    Schmaltz AA; Kandolf R
    Klin Padiatr; 2001; 213(1):1-7. PubMed ID: 11225467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of viral myocarditis.
    Schultz JC; Hilliard AA; Cooper LT; Rihal CS
    Mayo Clin Proc; 2009 Nov; 84(11):1001-9. PubMed ID: 19880690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should endomyocardial biopsy be performed for detection of myocarditis? A decision analytic approach.
    Hrobon P; Kuntz KM; Hare JM
    J Heart Lung Transplant; 1998 May; 17(5):479-86. PubMed ID: 9628566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy.
    Grogan M; Redfield MM; Bailey KR; Reeder GS; Gersh BJ; Edwards WD; Rodeheffer RJ
    J Am Coll Cardiol; 1995 Jul; 26(1):80-4. PubMed ID: 7797779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.